1 active warrant series covering 1,577,087 shares (~3.7% potential dilution); nearest expiry 2026-11-20.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.39 | Nov 20, 2026 51d | 1.6M | OTM | 3.7% | C$607K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
2 option grants covering 3,300,000 shares (~7.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.22 | May 1, 2031 1674d | 2.8M | OTM | 6.6% | C$616K | Auto |
| option | $0.34 | May 29, 2031 1702d | 500K | OTM | 1.2% | C$168K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
42,481,574 shares outstanding, plus 1,577,087 from warrants and 3,300,000 from options — a fully diluted 47,358,661 shares, or ~11.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
1 active warrant series covering 1,577,087 shares (~3.7% potential dilution); nearest expiry 2026-11-20.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.39 | Nov 20, 2026 51d | 1.6M | OTM | 3.7% | C$607K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
2 option grants covering 3,300,000 shares (~7.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.22 | May 1, 2031 1674d | 2.8M | OTM | 6.6% | C$616K | Auto |
| option | $0.34 | May 29, 2031 1702d | 500K | OTM | 1.2% | C$168K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
42,481,574 shares outstanding, plus 1,577,087 from warrants and 3,300,000 from options — a fully diluted 47,358,661 shares, or ~11.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
